What determines price for medical malpractice insurance?

Medical malpractice is a line with wide variation in premiums and claims outcomes across specialties and states. This guide covers the exposure bases, rating factors, actuarial methods, and market forces that make med mal pricing structurally distinct from every other commercial liability line.

• Specialty classification produces the widest multiplicative spread of any rating variable in P&C — an 8.0x factor range in filed class plans — yet low claim frequency means individual physician experience carries almost no credibility.

• State venue isn't a modifier; it's a regime. Illinois runs a 96.7% loss-and-DCC ratio while Maryland posts 57.6% on comparable premium volume.

• Claims-made step factors create a 3:1 pricing differential between first-year and mature policies — a structural dimension with zero analog in occurrence-form lines.

• Over half of claims now close without indemnity payment, but average paid severity in Washington State has reached $956,000 — meaning the pricing challenge is a bimodal distribution, not a simple frequency × severity product.

• Nuclear verdicts are no longer tail events: 57 MPL-specific verdicts exceeded $10 million in 2023, up 67% over the prior decade.

Exposure measures unique to medical malpractice

Med mal commonly uses physician-equivalent measures for individual coverage and occupied bed equivalents (OBEs) for hospitals — bases that differ from the payroll, revenue, or vehicle-based measures often used in WC, GL, or commercial auto.

Physician-years are objectively auditable and support specialty relativities as multiplicative factors, but they treat a high-volume surgical practice identically to a low-volume one within the same specialty. CAS research documents this as a known deficiency: premium based solely on specialty is unfairly favorable to high-volume providers. Procedure volume is theoretically superior but impractical as a primary base because claim frequency is too low to generate credible experience at that granularity.

OBEs capture actual patient throughput across inpatient, outpatient, surgical, and emergency settings, avoiding the static-bed-count problem. Gross patient revenue can be distorted by payer mix and charity care write-offs. All current MPL exposure bases are activity proxies rather than direct liability measures, as the AAA's COVID-19 stress test confirmed.

Rating factors that shape medical malpractice premiums

Physician specialty

Specialty is the single largest multiplicative component in every med mal rating plan. Filed class plans group specialties into roughly 10 rate groups, with AIG's SERFF filing showing factors from 1.000 (Class 1) to 8.000 (Class 5) — the widest single-variable spread in any P&C class plan. In a real-world physician and surgeons filing, the classification relativity of 1.950 exceeded territory, claims history, and all schedule elements combined.

The loss cost relativity between general surgeons and general practitioners holds at approximately 3:1 across states, even where absolute loss cost levels differ materially. This cross-jurisdictional stability makes specialty the most actuarially reliable rating variable — but low claim frequency means individual physician loss data has very low credibility, forcing heavy reliance on class rates. Ironically, high-risk specialties like neurosurgery and obstetrics show lower excess variance within their classes, making individual merit rating more statistically justified for the groups that least need it.

State venue and territory

Territory is the second core variable, but "territory" in med mal means something far more consequential than in GL or auto. The direct loss-and-DCC ratio spread across the top 10 premium states spans 39.1 percentage points — from Illinois at 96.7% to Maryland at 57.6%. Nearly three-quarters of all nuclear verdicts concentrate in just 10 states, with California, Florida, New York, and Texas producing half the national total.

Intra-state differentiation alone generates 30%+ premium differentials, driven by county-level jury composition and judicial venue characteristics. Non-economic damage caps range from $250,000 in states like Texas to higher statutory limits in some states, creating statutory severity ceilings that directly bound expected loss distributions. These aren't pricing refinements — they define fundamentally different risk regimes.

Claims-made maturity (step factors)

Step factors are structurally unique to claims-made lines. A first-year claims-made policy is often priced at roughly 35% of the mature rate, reflecting only current-year incident exposure. By year 5, the policy reaches 100%. This creates a mandatory rating dimension absent from every occurrence-form line.

Free tail coverage (extended reporting periods triggered by death, disability, or retirement) embeds an option that must be loaded into the base premium using demographic assumptions — age-based mortality, disability, and retirement rates — that have no parallel in GL, WC, or commercial auto ratemaking.

Claims history and schedule rating

Individual claims history operates through both experience rating (for larger risks with credible data) and schedule rating credits/debits. Filed plans may allow aggregate schedule debits and credits up to 25%. But the more consequential distinction is between priceable claims history and history that triggers declination.

Physicians with "troublesome" claims patterns — particularly those indicating conduct-based risk like substance impairment or practice outside competency — face binary declination rather than surcharge. Active licensure, board disciplinary status, and controlled substance prescribing authority function as hard underwriting gates with no continuous pricing alternative. The NPDB's cross-state, permanent tracking infrastructure makes this binary screening verifiable in a way no other commercial line can match. Risk management credits (0.4%) and part-time credits (3.8%) round out the schedule, but these are marginal adjustments compared to the binary gates that precede them.

Procedure volume

Actuarial research has discussed sources of cost variation within risk classes, but the specific CAS characterization described here could not be substantiated. In practice, volume is captured indirectly through part-time credits and, for hospitals, through OBE weighting rather than as a standalone continuous rating variable — constrained by the same low-frequency credibility problem that limits all individual-level med mal pricing.

How actuaries price with thin data and social inflation

Bornhuetter-Ferguson is commonly used for immature accident years because its a priori expected loss ratio stabilises estimates when individual year data are sparse or unstable, and this rationale is often cited for long-tailed, low-frequency lines such as medical malpractice. Frequency-severity separation is essential because med mal's bimodal severity distribution (mass at zero, heavy right tail) requires distinct modelling of the zero-payment probability and the non-zero severity tail using Pareto or Burr distributions. Cape Cod performs well in hindsight testing when applied to on-level-adjusted premium over stable rate adequacy periods, but its long-term averaging breaks down under social inflation's structural regime shifts. Calendar-year paid trend models remove development uncertainty entirely from severity trend estimation, addressing the stair-step pattern where incurred methods systematically understate severity jumps — since med mal produces virtually no partial payments, incurred data lags severity shifts more than in any other line. Berquist-Sherman adjustments can be used to address distortions in triangle-based reserving data when settlement rates or case reserve adequacy have changed.

What's shaping medical malpractice pricing now

Severity is accelerating: Milliman now applies a 5.0% annual closed-claim severity trend, up from the 3–4% assumptions of the prior decade. Average paid indemnity in Washington State reached $952,982 in 2024, with the median at $368,750. Nuclear verdicts above $100 million hit an all-time high in 2023, increasing approximately 400% over the study baseline.

Frequency remains low. Defence costs were affected by volatility tied to claim backlogs. NAIC reported a net loss ratio of 71.2% in 2024, with absolute losses still increasing; the improvement reflected premium growth outpacing loss growth. AM Best expects lower reserve redundancies ahead as social inflation embeds in adverse development patterns. MPL specialty writers, meanwhile, posted 20-year highs in direct written premium and surplus in Q2 2025.

How hx supports Medical Malpractice insurance pricing

Configurable pricing logic for complex rating structures

Medical Malpractice's unique challenges require pricing logic that standard raters struggle to express. The hx Decision Engine lets actuaries implement these rules in native Python—including knockout criteria, coverage-specific calculations, and control interactions—then deploy changes with full governance and version control.

Med Mal's 8:1 specialty classification spread and claims-made step factors (30%→100% of mature premium) require multidimensional rating logic that static raters can't express. hx's Decision Engine implements these specialty relativities, step schedules, and tail factor adjustments in native Python with full version control.

Submission triage aligned to appetite

Medical Malpractice submissions arrive with documentation that determines both insurability and pricing tier. hx Submission Triage extracts this data from unstructured broker submissions and surfaces it alongside appetite checks and indicative pricing, so underwriters can identify gaps before investing time in full analysis.

Physicians with NPDB-reportable events or license suspensions trigger binary declination gates before pricing even begins. hx automatically routes these high-risk submissions to senior underwriters while fast-tracking clean risks through automated appetite filters tied to state venue and specialty class.

Portfolio intelligence for aggregation management

Medical Malpractice's systemic risk requires portfolio-level visibility that policy-by-policy pricing can't provide. hx Portfolio Intelligence enables batch rating, what-if analysis, and concentration monitoring to support regulatory reporting requirements.

Tail exposure should be scenario-modeled across state jurisdictions. hx aggregates Med Mal books by specialty, state tort environment, and claims-made maturity year to stress-test social inflation scenarios in real time.

Audit trails for evolving regulatory requirements

With increasing regulatory scrutiny, actuaries need documented lineage from model assumptions to individual policy pricing decisions. hx captures every action automatically, creating the governance trail Medical Malpractice's regulatory environment demands.

Frequent tort reform changes (Florida 2023, Georgia 2025) and evolving damages rules require auditable documentation of when rating factors changed and why. hx maintains complete version history of specialty relativities, territory factors, and step schedules with timestamped regulatory justification for every rate adjustment.

Explore hx for Medical Malpractice insurance →

This guide is part of Hyperexponential's insurance pricing resource library. For more information on how hx supports Medical Malpractice pricing, contact us.